PT  - JOURNAL ARTICLE
AU  - Sylvester, Bruce
ED  - Teo, Koon
TI  - Mixed Results with Telmisartan in ACE-Intolerant Patients with Diabetes or High-Risk Vascular Disease
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 16--16
VI  - 8
IP  - 6
4099  - http://mdc.sagepub.com/content/8/6/16.short
4100  - http://mdc.sagepub.com/content/8/6/16.full
AB  - Telmisartan did not reduce the primary composite of cardiovascular death, myocardial infarction, stroke, or hospitalization for heart failure in patients with diabetes or high-risk vascular disease who are unable to tolerate standard treatment with angiotensin-converting enzyme inhibitors, according to findings from the Telmisartan Randomized AssessmeNt Study in aCE iNtolerant subjects with cardiovascular Disease [TRANSCEND; NCT00153101] Trial.